+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Therapeutics Market Size, Share & Trends Analysis Report by Application (Diabetes, Obesity), End-use (Patients, Providers, Payers, Employers), and Region with Growth Forecasts, 2025-2030- Product Image
Digital Therapeutics Market Size, Share & Trends Analysis Report by Application (Diabetes, Obesity), End-use (Patients, Providers, Payers, Employers), and Region with Growth Forecasts, 2025-2030- Product Image
New

Digital Therapeutics Market Size, Share & Trends Analysis Report by Application (Diabetes, Obesity), End-use (Patients, Providers, Payers, Employers), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4375431
Description Jump to:
The Digital Therapeutics Market was valued at USD 7.67 billion in 2024, and is projected to reach USD 32.5 billion by 2030, rising at a CAGR of 27.77%. The primary driver for expanding the market growth is the increased use of smartphones. The affordability of digital health technologies for healthcare providers & patients, rising demand for integrated healthcare systems, and care focusing on the patient are key factors fueling the market's growth. Furthermore, the growing globalization and shifts in lifestyle habits, such as higher rates of tobacco use, inadequate nutrition, insufficient physical activity, and rising alcohol consumption, increase the likelihood of chronic disease development.

The market’s expansion is significantly influenced by the increasing adoption of digital therapeutics and the supportive initiatives by leading regulatory agencies such as the FDA. For instance, the U.S. FDA provided guidelines in April 2020 to enhance the reach of digital therapeutic devices for people suffering from psychiatric disorders. Furthermore, according to Kepios data, there's a 7.6% annual growth rate in the global internet user base, translating to around 900,000 new internet users daily. While developed and developing nations boast high smartphone and internet usage levels, areas such as Africa and South Asia need to catch up due to their economic limitations.

Increasing prevalence of chronic diseases is also driving the growth of the market. As per the CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have two or more chronic diseases. For instance, in February 2022, Teladoc Health, Inc. launched Chronic Care Complete, a chronic condition management solution to improve healthcare outcomes. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer’s have been identified as the leading causes of death and disability in the country.

Digital therapeutics have become an essential option for treating various health conditions, mainly due to customized treatment plans and strategic initiatives by leading companies in the industry. These actions include mergers and acquisitions, clearing regulatory approvals, introducing new products, and establishing partnerships. Moreover, the growing rates of chronic diseases such as cardiovascular disease, diabetes, and anxiety have driven critical players in the market to invest in digital solutions for treatment. Various companies are in the process of developing digital therapeutic products aimed specifically at managing anxiety, with many of these products in different phases of research and development. This presents a significant opportunity for market growth. For instance, In August 2023, Welldoc revealed it had obtained its 10th FDA 510(k) clearance for the BlueStar digital health solution for diabetes management. This clearance allows BlueStar to incorporate connected insulin dosing information into its customized recommendations for bolus insulin dosing.

Digital Therapeutics Market Report Highlights

  • The diabetes segment dominated the market with largest market share of 29.75% in 2024 and is expected to register the fastest CAGR over the forecast period.
  • The patient segment held the largest market share of 34.50% in 2024 and is anticipated to register the fastest growth rate over the forecast period, owing to patients' rapid adoption of digital therapeutics.
  • North America digital therapeutics industry dominated globally with a revenue share of 40.11% in 2024.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Digital Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Digital Therapeutics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Digital Therapeutics Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Digital Therapeutics Market, by Application Outlook
4.4. Diabetes
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Obesity
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Cardiovascular Disease (CVD)
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Respiratory Diseases
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.8. Smoking Cessation
4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.9. Central Nervous System (CNS) Disease
4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Digital Therapeutics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Digital Therapeutics Market, by End Use Outlook
5.4. Patients
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Providers
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Payers
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Employers
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Digital Therapeutics Market: Regional Estimates & Trend Analysis, By Application, By End Use
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Denmark
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Norway
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.9. Rest of Europe
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework/ reimbursement structure
6.6.9.3. Competitive scenario
6.6.9.4. Rest of Europe market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7.7. Rest of Asia Pacific
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework/ reimbursement structure
6.7.7.3. Competitive scenario
6.7.7.4. Rest of Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Rest of Latin America
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Rest of Latin America market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
6.9.5. Rest of MEA
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework/ reimbursement structure
6.9.5.3. Competitive scenario
6.9.5.4. Rest of MEA market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Profiles
7.3.1. OMADA HEALTH, INC.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Welldoc, Inc.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. 2Morrow, Inc
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Livongo Health, Inc. (Teladoc Health, Inc.)
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Propeller Health (ResMed)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Fitbit LLC
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Mango Health
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. CANARY HEALTH
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Noom, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Pear Therapeutics, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Akili Interactive Labs, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. HYGIEIA
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. DarioHealth Corp.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. BigHealth
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. GAIA AG
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Limbix Health, Inc.
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives
List of Tables
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 North America digital therapeutics market estimates and forecasts, by country, 2018-2030 (USD Million)
TABLE 4 North America digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 5 North America digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 7 U.S. macro dynamics
TABLE 8 U.S. digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 9 U.S. digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 10 Canada macro dynamics
TABLE 11 Canada digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 12 Canada digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 13 Mexico macro dynamics
TABLE 14 Mexico digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 15 Mexico digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 16 Europe digital therapeutics market estimates and forecasts, by country, 2018-2030 (USD Million)
TABLE 17 Europe digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 18 Europe digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 19 UK macro dynamics
TABLE 20 UK digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 21 UK digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 22 Germany macro dynamics
TABLE 23 Germany digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 24 Germany digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 25 France macro dynamics
TABLE 26 France digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 27 France digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 28 Italy macro dynamics
TABLE 29 Italy digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 30 Italy digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 31 Spain macro dynamics
TABLE 32 Spain digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 33 Spain digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 34 Denmark macro dynamics
TABLE 35 Denmark digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 36 Denmark digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 37 Sweden macro dynamics
TABLE 38 Sweden digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 39 Sweden digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 40 Norway macro dynamics
TABLE 41 Norway digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 42 Norway digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 43 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018-2030 (USD Million)
TABLE 44 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 45 Asia Pacific digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 46 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018-2030 (USD Million)
TABLE 47 Japan macro dynamics
TABLE 48 Japan digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 49 Japan digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 50 China macro dynamics
TABLE 51 China digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 52 China digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 53 India macro dynamics
TABLE 54 India digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 55 India digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 56 Australia Macro dynamics
TABLE 57 Australia digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 58 Australia digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 59 Thailand macro dynamics
TABLE 60 Thailand digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 61 Thailand digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 62 South Korea macro dynamics
TABLE 63 South Korea digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 64 South Korea digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 65 Latin America digital therapeutics market estimates and forecasts, by country, 2018-2030 (USD Million)
TABLE 66 Latin America digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 67 Latin America digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 68 Brazil macro dynamics
TABLE 69 Brazil digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 70 Brazil digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 71 Argentina macro dynamics
TABLE 72 Argentina digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 73 Argentina digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 74 MEA digital therapeutics market estimates and forecasts, by country, 2018-2030 (USD Million)
TABLE 75 MEA digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 76 MEA digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 77 South Africa macro dynamics
TABLE 78 South Africa digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 79 South Africa digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 80 Saudi Arabia Macro dynamics
TABLE 81 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 82 Saudi Arabia digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 83 UAE Macro dynamics
TABLE 84 UAE digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 85 UAE digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 86 Kuwait Macro dynamics
TABLE 87 Kuwait digital therapeutics market estimates and forecasts, by application, 2018-2030 (USD Million)
TABLE 88 Kuwait digital therapeutics market estimates and forecasts, by end use, 2018-2030 (USD Million)
TABLE 89 Key company heat map analysis/company position analysis
List of Figures
Figure 1 Market segmentation
Figure 2 Market research process
Figure 3 Estimation methodology
Figure 4 Data triangulation techniques
Figure 5 Primary research pattern
Figure 6 Market research approaches
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD modeling for market share assessment
Figure 9 Market formulation & validation
Figure 10 Commodity flow analysis
Figure 11 Digital therapeutics market snapshot, 2024 (USD Million)
Figure 12 Segment snapshot
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook
Figure 15 Ancillary market outlook
Figure 16 Digital Therapeutics market dynamics
Figure 17 Digital therapeutics market driver impact
Figure 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
Figure 19 Top countries by smartphone users, 2021
Figure 20 Digital therapeutics market restraint impact
Figure 21 Market participation categorization
Figure 22 Market leaders and innovators
Figure 23 Company market position analysis
Figure 24 Major deals & strategic alliances analysis
Figure 25 Digital therapeutics market: Application movement analysis
Figure 26 Digital therapeutics Market: Application dashboard
Figure 27 Global diabetes market, 2018-2030 (USD Million)
Figure 28 Global obesity market, 2018-2030 (USD Million)
Figure 29 Global CVD market, 2018-2030 (USD Million)
Figure 30 Global respiratory diseases market, 2018-2030 (USD Million)
Figure 31 Global smoking cessation market, 2018-2030 (USD Million)
Figure 32 Global CNS diseases market, 2018-2030 (USD Million)
Figure 33 Global others market, 2018-2030 (USD Million)
Figure 34 Digital therapeutics market: End Use movement analysis
Figure 35 Digital therapeutics market: End Use dashboard
Figure 36 Global patients market, 2018-2030 (USD Million)
Figure 37 Global providers market, 2018-2030 (USD Million)
Figure 38 Global payers market, 2018-2030 (USD Million)
Figure 39 Global employers market, 2018-2030 (USD Million)
Figure 40 Global other end uses market, 2018-2030 (USD Million)
Figure 41 Regional marketplace: Key takeaways
Figure 42 North America: SWOT analysis
Figure 43 North America digital therapeutics market, 2018-2030 (USD Million)
Figure 44 U.S. digital therapeutics market, 2018-2030 (USD Million)
Figure 45 Canada digital therapeutics market, 2018-2030 (USD Million)
Figure 45 Mexico digital therapeutics market, 2018-2030 (USD Million)
Figure 46 Europe: SWOT analysis
Figure 47 Europe digital therapeutics market, 2018-2030 (USD Million)
Figure 48 UK digital therapeutics market, 2018-2030 (USD Million)
Figure 49 Germany digital therapeutics market, 2018-2030 (USD Million)
Figure 50 France digital therapeutics market, 2018-2030 (USD Million)
Figure 51 Italy digital therapeutics market, 2018-2030 (USD Million)
Figure 52 Spain digital therapeutics market, 2018-2030 (USD Million)
Figure 53 Sweden digital therapeutics market, 2018-2030 (USD Million)
Figure 54 Norway digital therapeutics market, 2018-2030 (USD Million)
Figure 55 Denmark digital therapeutics market, 2018-2030 (USD Million)
Figure 56 Asia Pacific: SWOT analysis
Figure 57 Asia Pacific Digital Therapeutics market, 2018-2030 (USD Million)
Figure 58 Japan digital therapeutics market, 2018-2030 (USD Million)
Figure 59 China digital therapeutics market, 2018-2030 (USD Million)
Figure 60 India digital therapeutics market, 2018-2030 (USD Million)
Figure 61 Australia digital therapeutics market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 62 South Korea digital therapeutics market estimates and forecasts, 2016-2030 (USD Million)
Figure 63 Thailand digital therapeutics market estimates and forecasts, 2016-2030 (USD Million)
Figure 64 Latin America: SWOT analysis
Figure 65 Latin America digital therapeutics market, 2018-2030 (USD Million)
Figure 66 Mexico digital therapeutics market, 2018-2030 (USD Million)
Figure 67 Brazil digital therapeutics market, 2018-2030 (USD Million)
Figure 68 Argentina digital therapeutics market, 2018-2030 (USD Million)
Figure 69 Middle East and Africa: SWOT analysis
Figure 70 Middle East and Africa digital therapeutics market, 2018-2030 (USD Million)
Figure 71 South Africa digital therapeutics market, 2018-2030 (USD Million)
Figure 72 Saudi Arabia digital therapeutics market, 2018-2030 (USD Million)
Figure 73 UAE digital therapeutics market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Kuwait digital therapeutics market revenue estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Heat map analysis
Figure 76 List of key emerging companies/technology disruptors/innovators

Companies Mentioned

The major companies featured in this Digital Therapeutics market report include:
  • OMADA HEALTH, INC.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Livongo Health, Inc. (Teladoc Health, Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Mango Health
  • CANARY HEALTH
  • Noom, Inc.
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth Corp.
  • BigHealth
  • GAIA AG
  • Limbix Health, Inc.

Related Topics

Related Reports

Digital Therapeutic Devices Market by Therapeutic Area, Product Type, Delivery Mode, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Digital Therapeutic Devices Market by Therapeutic Area, Product Type, Delivery Mode, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Digital Therapeutics Market by Therapeutic Area, Delivery Mode, End User, Application, Distribution Channel, Pricing Model, Deployment Model - Global Forecast to 2030 - Product Image

Digital Therapeutics Market by Therapeutic Area, Delivery Mode, End User, Application, Distribution Channel, Pricing Model, Deployment Model - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Digital Therapeutics Market Outlook to 2029 - Product Image

Digital Therapeutics Market Outlook to 2029

  • Report
  • 85 Pages
  • Global
From
Digital Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business and Key Geographical RegionsModel, Target Therapeutic Area - Product Image

Digital Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business and Key Geographical RegionsModel, Target Therapeutic Area

  • Report
  • 565 Pages
  • Global
From
Digital Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Digital Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.